Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US40650V1008
Ticker AVNS
Company AVANOS MEDICAL
Currency $
Price
Aware Investor Index (AII) 0.0002
Recommendation STRONG SELL
P/E 69.81
ROE 2.65 %
Capitalization 2,246,868,000 $
Dividend Yield 0.00 %
P/S 3.67
AII Position 704
P/E Position 662
ROE Position 697
Capitalization Position 638
Dividend Yield Position 595
Sales 611,600,000 $
10-Year Average Earnings 32,187,500 $
Shares Outstanding 46,800,000
Equity 1,215,400,000 $
Dividend per Share 0 $
Industry Healthcare
Country United States
AVANOS MEDICAL Investor Relations Web Site https://halyardhealth.investorroom.com/







Sales:

YEAR MONTH AMOUNT
2017 12 611,600,000.00 $
2016 12 566,200,000.00 $
2015 12 509,000,000.00 $
2014 12 501,600,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 79,300,000.00 $
2016 12 39,800,000.00 $
2015 12 -426,300,000.00 $
2014 12 27,100,000.00 $
2013 12 154,600,000.00 $
2012 12 152,600,000.00 $
2011 12 142,400,000.00 $
2010 12 88,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 1,215,400,000.00 $
2016 12 1,102,500,000.00 $
2015 12 1,055,300,000.00 $
2014 12 1,491,200,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 46,800,000
2016 12 46,600,000
2015 12 46,600,000
2014 12 46,538,000

 












Bloomberg News for AVANOS MEDICAL:



Google News for AVANOS MEDICAL:

Marea Informative (blog) - 19 hours ago
Avanos Medical (AVNS) Releases FY 2018 Earnings Guidance
Avanos Medical (NYSE:AVNS) updated its FY 2018 earnings guidance on Tuesday. The company provided earnings per share (EPS) ...
Lakeland Observer
2976 Shares in Avanos Medical Inc (NYSE:AVNS) Acquired by First ...
First National Bank & Trust Co. of Newtown acquired a new stake in shares of Avanos Medical Inc (NYSE:AVNS) during the 3rd quarter, ...
Stock Voice
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2018 Results ...
Avanos Medical, Inc. (NYSE:AVNS) Q3 2018 Results Earnings Conference Call November 6, 2018 9:00 AM ET. Executives. Dave Crawford ...
Wall Street Morning
Avanos Medical (AVNS) to gain $62.29 in short term period
Avanos Medical (AVNS) stock managed performance -1.92% over the last week and switched with performance of -19.98% throughout past one month period.
Marea Informative (blog) - 7 hours ago
North Star Asset Management Inc. Takes Position in Avanos Medical ...
North Star Asset Management Inc. bought a new position in Avanos Medical Inc (NYSE:AVNS) in the 3rd quarter, according to its most recent ...
Fairfield Current
Avanos Medical, Inc. To Webcast Conference Call Discussing Third ...
ALPHARETTA, Ga., Oct. 23, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial ...
Lakeland Observer
Arrowhead Pharmaceuticals, Inc. (ARWR) registers a price change ...
Arrowhead Pharmaceuticals, Inc. (ARWR) registers a price change of -2.81% while Avanos Medical, Inc. (AVNS) finishes with a flow of -3.13%.
Baseball Daily News
Brokerages Set Avanos Medical Inc (AVNS) PT at $68.67
Avanos Medical Inc (NYSE:AVNS) has been given an average recommendation of “Hold” by the six analysts that are currently covering the ...
Seeking Alpha - 6 Nov 2018
Stock Under Active Eyes: Inovio Pharmaceuticals (INO), Avanos ...
Avanos Medical (AVNS) stock traded 352332 shares in recent trading session on Friday. The stock average volume of shares counted at ...
Nasdaq
Avanos Medical (AVNS) Cut to “C” at TheStreet
AVNS has been the subject of several other reports. Zacks Investment Research lowered Avanos Medical from a hold rating to a sell rating in a ...


Back